NCT03112746 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Carswell A, McColl MA, Baptiste S, Law M, Polatajko H, Pollock N
The Canadian Occupational Performance Measure: a research and clinical literature review. Can J Occup Ther. 2004 Oct;71(4):210-22. Review.
Green D, Chambers ME, Sugden DA
Does subtype of developmental coordination disorder count: is there a differential effect on outcome following intervention? Hum Mov Sci. 2008 Apr;27(2):363-82. doi: 10.1016/j.humov.2008.02.009. Epub 2008 Apr 8.
Mandich AD, Polatajko HJ, Macnab JJ, Miller LT
Treatment of children with Developmental Coordination Disorder: what is the evidence? Phys Occup Ther Pediatr. 2001;20(2-3):51-68. Review.
Mandich AD, Polatajko HJ, Rodger S
Rites of passage: understanding participation of children with developmental coordination disorder. Hum Mov Sci. 2003 Nov;22(4-5):583-95.
Miller LT, Polatajko HJ, Missiuna C, Mandich AD, Macnab JJ
A pilot trial of a cognitive treatment for children with developmental coordination disorder. Hum Mov Sci. 2001 Mar;20(1-2):183-210.

Efficacy of the Cognitive Orientation to Daily Occupational Performance (CO-OP) Approach With Brazilian Children With Developmental Coordination Disorder

Details for clinical trial NCT03112746

Clinical trial NCT03112746 - References